SE462893B - Vattenhaltig parenteral loesning av vaevnadsplasminogenaktivator och saett foer framstaellning av den - Google Patents

Vattenhaltig parenteral loesning av vaevnadsplasminogenaktivator och saett foer framstaellning av den

Info

Publication number
SE462893B
SE462893B SE8602404A SE8602404A SE462893B SE 462893 B SE462893 B SE 462893B SE 8602404 A SE8602404 A SE 8602404A SE 8602404 A SE8602404 A SE 8602404A SE 462893 B SE462893 B SE 462893B
Authority
SE
Sweden
Prior art keywords
parenteral solution
solution according
parenteral
solution
concentration
Prior art date
Application number
SE8602404A
Other languages
English (en)
Swedish (sv)
Other versions
SE8602404L (sv
SE8602404D0 (sv
Inventor
Michael Denis Johnston
Henry Berger
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858513358A external-priority patent/GB8513358D0/en
Priority claimed from GB858521704A external-priority patent/GB8521704D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE8602404D0 publication Critical patent/SE8602404D0/xx
Publication of SE8602404L publication Critical patent/SE8602404L/xx
Publication of SE462893B publication Critical patent/SE462893B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SE8602404A 1985-05-28 1986-05-27 Vattenhaltig parenteral loesning av vaevnadsplasminogenaktivator och saett foer framstaellning av den SE462893B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation
GB858521704A GB8521704D0 (en) 1985-08-31 1985-08-31 Formulation

Publications (3)

Publication Number Publication Date
SE8602404D0 SE8602404D0 (sv) 1986-05-27
SE8602404L SE8602404L (sv) 1986-11-29
SE462893B true SE462893B (sv) 1990-09-17

Family

ID=26289289

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602404A SE462893B (sv) 1985-05-28 1986-05-27 Vattenhaltig parenteral loesning av vaevnadsplasminogenaktivator och saett foer framstaellning av den

Country Status (22)

Country Link
US (1) US5112609A (de)
AT (1) AT391812B (de)
AU (1) AU569429B2 (de)
BE (1) BE904831A (de)
CA (1) CA1297008C (de)
CH (1) CH664495A5 (de)
DE (1) DE3617753A1 (de)
DK (1) DK163174C (de)
ES (1) ES8706443A1 (de)
FI (1) FI85334C (de)
FR (1) FR2593393B1 (de)
GB (1) GB2176703B (de)
GR (1) GR861365B (de)
HU (1) HU200695B (de)
IL (1) IL78937A (de)
IT (1) IT1191925B (de)
LU (1) LU86445A1 (de)
NL (1) NL8601354A (de)
NO (1) NO171344C (de)
NZ (1) NZ216306A (de)
PT (1) PT82647B (de)
SE (1) SE462893B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX197183A (es) * 1982-05-05 1994-02-28 Genentech Inc Activador de plasminogeno de tejido humano
US5185259A (en) * 1982-05-05 1993-02-09 Genentech, Inc. Truncated human tissue plasminogen activator
FI831484L (fi) 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
WO1986005096A1 (en) * 1985-03-06 1986-09-12 Survival Technology, Inc. Protein absorption enhancing agents
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
US5034225A (en) * 1985-12-17 1991-07-23 Genentech Inc. Stabilized human tissue plasminogen activator compositions
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
BE1001425A4 (fr) * 1986-05-12 1989-10-31 Wellcome Found Utilisation de l'activateur tissulaire du plasminogene, son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association.
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments
WO1990001334A1 (en) * 1988-08-05 1990-02-22 Codon Formulations for plasminogen activator using aspartate
GB8819607D0 (en) * 1988-08-17 1988-09-21 Wellcome Found Novel combination
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
GB9000629D0 (en) * 1990-01-11 1990-03-14 Porton Prod Ltd Tissue plasminogen activator
DE10199044I2 (de) * 1992-06-03 2006-02-09 Genentech Inc Varianten des Gewebeplasminogenaktivators mit verbesserter Therapeutischer wirkung
US6139838A (en) * 1996-09-06 2000-10-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Tissue plasminogen activator medicinal composition
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
KR20040062535A (ko) * 2001-09-07 2004-07-07 글로벌 바이오텍 인코포레이티드 인간 조직 유로키나아제형 플라스미노겐 활성화제 배합물
JP2011522538A (ja) * 2008-06-04 2011-08-04 タレクリス・バイオセラピユーテイクス・インコーポレーテツド プラスミン製造のための組成物、方法およびキット
PT2403865E (pt) 2009-03-03 2015-11-18 Grifols Therapeutics Inc Métodos de preparação de plasminogénio

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
FR2252842B1 (de) * 1973-12-03 1977-11-04 Fabre Sa Pierre
DE3015699C2 (de) * 1979-04-26 1982-07-15 Asahi Kasei Kogyo K.K., Osaka Herstellung eines Plasminogen-Aktivators
CA1154671A (fr) * 1979-07-27 1983-10-04 Lucien D. D'hinterland Separation d'un activateur tissulaire du plasminogene
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
GB2138824B (en) * 1982-10-29 1986-12-31 Mitsui Toatsu Chemicals Novel plasminogen activator process for its preparation and thrombolytic drug containing the same
EP0112122B1 (de) * 1982-12-14 1991-08-28 South African Inventions Development Corporation Plasminogenaktivator
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
DE3439980A1 (de) * 1984-11-02 1986-05-07 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung sowie pasteurisierung von urokinase
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
EP0417662B1 (de) * 1989-09-13 1995-12-13 Maschinenfabrik Rieter Ag Verfahren zum Starten eines Arbeitsablaufs eines Bedienungsautomaten an einer Textilmaschine

Also Published As

Publication number Publication date
DE3617753C2 (de) 1988-06-30
PT82647A (en) 1986-06-01
ATA141186A (de) 1990-06-15
CH664495A5 (de) 1988-03-15
NL8601354A (nl) 1986-12-16
DE3617753A1 (de) 1986-12-04
GB2176703B (en) 1988-12-07
IT8648064A0 (it) 1986-05-27
FI85334B (fi) 1991-12-31
US5112609A (en) 1992-05-12
DK163174B (da) 1992-02-03
SE8602404L (sv) 1986-11-29
GB2176703A (en) 1987-01-07
HUT42330A (en) 1987-07-28
CA1297008C (en) 1992-03-10
NO862095L (no) 1986-12-01
FR2593393A1 (fr) 1987-07-31
HU200695B (en) 1990-08-28
NZ216306A (en) 1989-10-27
AT391812B (de) 1990-12-10
AU569429B2 (en) 1988-01-28
FR2593393B1 (fr) 1989-06-02
DK246886A (da) 1986-11-29
ES8706443A1 (es) 1987-07-01
SE8602404D0 (sv) 1986-05-27
FI862226A (fi) 1986-11-29
IL78937A (en) 1990-11-29
GR861365B (en) 1986-09-29
DK246886D0 (da) 1986-05-27
BE904831A (fr) 1986-11-27
ES555352A0 (es) 1987-07-01
AU5796586A (en) 1986-12-04
IL78937A0 (en) 1986-09-30
NO171344C (no) 1993-03-03
GB8612781D0 (en) 1986-07-02
FI862226A0 (fi) 1986-05-27
DK163174C (da) 1992-06-22
FI85334C (fi) 1992-04-10
IT1191925B (it) 1988-03-31
NO171344B (no) 1992-11-23
LU86445A1 (fr) 1986-12-05
PT82647B (pt) 1989-01-30

Similar Documents

Publication Publication Date Title
SE462893B (sv) Vattenhaltig parenteral loesning av vaevnadsplasminogenaktivator och saett foer framstaellning av den
SE462016B (sv) Foerfarande foer iordningsstaellande av en lyofiliserad farmaceutisk sammansaettning med vaevnadsplasminogen-aktivator, t-pa
JP4589018B2 (ja) エリスロポエチン溶液製剤
US7173008B2 (en) Lyophilized HGF preparations
JP3537440B2 (ja) 可溶性トロンボモジュリンを長期保存安定化させる方法
AU2022211908B2 (en) Subcutaneous administration of adamts13
JP3822383B2 (ja) 可溶性トロンボモジュリン含有組成物
JP2916947B2 (ja) Ｃｐｂ―ｉの安定化方法及び製剤組成物
CA2475738A1 (en) Activated protein c formulations
JPH0369332B2 (de)
JP2916948B2 (ja) Ｃｐｂ―ｉの安定化方法及びこの製剤組成物
NZ229611A (en) A bolus formulation containing at least 12.5 mu of t-pa
KR20150069962A (ko) 인자 vii의 융합 단백질을 포함하는 안정성이 개선된 약학적 조성물

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8602404-9

Effective date: 19941210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8602404-9

Format of ref document f/p: F